"Glioma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
| Descriptor ID |
D005910
|
| MeSH Number(s) |
C04.557.465.625.600.380 C04.557.470.670.380 C04.557.580.625.600.380
|
| Concept/Terms |
Glioma- Glioma
- Gliomas
- Glial Cell Tumors
- Glial Cell Tumor
- Tumor, Glial Cell
- Tumors, Glial Cell
Mixed Glioma- Mixed Glioma
- Glioma, Mixed
- Gliomas, Mixed
- Mixed Gliomas
Malignant Glioma- Malignant Glioma
- Glioma, Malignant
- Gliomas, Malignant
- Malignant Gliomas
|
Below are MeSH descriptors whose meaning is more general than "Glioma".
Below are MeSH descriptors whose meaning is more specific than "Glioma".
This graph shows the total number of publications written about "Glioma" by people in this website by year, and whether "Glioma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 3 | 2 | 5 |
| 1998 | 2 | 0 | 2 |
| 1999 | 0 | 2 | 2 |
| 2000 | 3 | 2 | 5 |
| 2001 | 1 | 0 | 1 |
| 2002 | 2 | 1 | 3 |
| 2003 | 3 | 0 | 3 |
| 2004 | 1 | 1 | 2 |
| 2005 | 3 | 0 | 3 |
| 2006 | 4 | 1 | 5 |
| 2007 | 5 | 0 | 5 |
| 2008 | 12 | 0 | 12 |
| 2009 | 9 | 1 | 10 |
| 2010 | 19 | 1 | 20 |
| 2011 | 13 | 3 | 16 |
| 2012 | 8 | 0 | 8 |
| 2013 | 13 | 2 | 15 |
| 2014 | 10 | 2 | 12 |
| 2015 | 12 | 0 | 12 |
| 2016 | 10 | 1 | 11 |
| 2017 | 13 | 1 | 14 |
| 2018 | 10 | 1 | 11 |
| 2019 | 13 | 1 | 14 |
| 2020 | 8 | 2 | 10 |
| 2021 | 14 | 0 | 14 |
| 2022 | 20 | 0 | 20 |
| 2023 | 22 | 0 | 22 |
| 2024 | 15 | 4 | 19 |
| 2025 | 14 | 0 | 14 |
| 2026 | 3 | 1 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glioma" by people in Profiles.
-
Incidence and predictors of hemorrhage in pediatric low-grade glioma. J Neurooncol. 2026 Jul 07; 178(3).
-
Glyoxalase 1 promotes glioma progression by modulating Sox2 transcriptional networks in glioma stem-like cells. Neuro Oncol. 2026 Jul 01; 28(7):1680-1693.
-
Hp1bp3 loss links chromatin reorganization to metabolic vulnerability in glioma. Proc Natl Acad Sci U S A. 2026 Jun 16; 123(24):e2601061123.
-
H3K27me3 spreading organizes canonical PRC1 chromatin architecture to regulate developmental programs. Nat Genet. 2026 Jun; 58(6):1368-1382.
-
Diffuse pediatric-type high grade glioma, RTK1 subtype, subclass C with SYN2::PPARG fusion in an older adult. CNS Oncol. 2026 Dec; 15(1):2641996.
-
Microbial signals in primary and metastatic brain tumors. Nat Med. 2025 Nov; 31(11):3675-3688.
-
EZHIP boosts neuronal-like synaptic gene programs and depresses polyamine metabolism. Acta Neuropathol Commun. 2025 11 07; 13(1):227.
-
Acrolein-induced PKM2 modification drives NETosis and glioma progression. Free Radic Biol Med. 2025 Dec 16; 241:567-581.
-
Neuro-Cancer Interactions Shape Glioma Intratumoral Heterogeneity. Adv Sci (Weinh). 2025 Oct; 12(38):e06694.
-
High-grade glioma with pleomorphic and pseudopapillary features: a single-institution series of three cases. Acta Neuropathol Commun. 2025 08 18; 13(1):176.